Dmvac

1. Dmvac decreases melanoma in mice.

   “leading to significant suppression of tumor progression”

   Animalsmelanoma in aged mice

   A Biomimetic Nanovesicle-Based Synthetic Vaccine Platform Through Co-Anchoring Oxidized Phospholipid and CpG for Rejuvenating Antitumor Immunity in Aged Mice

   Angewandte Chemie (International ed. in English)·10 Mar 2026

More on Melanoma

1. Dmvac increases cytotoxic T-cell responses in mice.

   “stimulating robust cytotoxic T-cell responses and memory formation in aged mice”

   Animalsaged mice

   A Biomimetic Nanovesicle-Based Synthetic Vaccine Platform Through Co-Anchoring Oxidized Phospholipid and CpG for Rejuvenating Antitumor Immunity in Aged Mice

   Angewandte Chemie (International ed. in English)·10 Mar 2026

1. Dmvac increases dendritic cell activation in mice.

   “The resulting dMVac reverses age-related DC dysfunction by enhancing their activation, migration, and IL-1β secretion”

   Animalsaged mice

   A Biomimetic Nanovesicle-Based Synthetic Vaccine Platform Through Co-Anchoring Oxidized Phospholipid and CpG for Rejuvenating Antitumor Immunity in Aged Mice

   Angewandte Chemie (International ed. in English)·10 Mar 2026